Imidazole compounds

US6437147B1 · kind B1 · utility

Assignees

• Novo Nordisk Inc. · DK
• Boehringer Ingelheim International GmbH · DE

Inventors

• Knud Erik Andersen
• Florencio Zaragoza Dorwald · Rang Taché Est, DK
• Bernd Peschke · Thisted, DK
• Ulla Grove Sidelmann · Hørsholm, DK
• Klaus Rudolf · Warthausen, DE
• Dirk Stenkamp · Biberach, DE
• Rudolf Hurnaus · Großenhain, DE
• Stephan Muller · Warthausen, DE
• Bernd Krist · Wien, AT
• Birgitte L. Eriksen · Farum, DK

Key dates

• Filing date: Mar 16, 2001
• Grant date: Aug 20, 2002
• Expiry date: Mar 16, 2021

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D235/04
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

A novel class of imidazo heterocyclic compounds, pharmaceutical compositions comprising them and use thereof in the treatment and/or prevention of diseases and disorders related to the histamine H3 receptor. More particularly, the compounds are useful for the treatment and/or prevention of diseases and disorders in which an interaction with the histamine H3 receptor is beneficial.